Inferensys

Glossary

IgFold

A specialized deep learning model that performs rapid, template-free prediction of antibody variable domain structures directly from sequence data.
Data scientist building training data pipeline on laptop, data preprocessing visible, technical workspace.
ANTIBODY STRUCTURE PREDICTION

What is IgFold?

IgFold is a specialized deep learning model that performs rapid, template-free prediction of antibody variable domain structures directly from sequence data.

IgFold is a deep learning architecture designed specifically for the de novo prediction of antibody Fv (variable fragment) structures from primary amino acid sequences. Unlike general-purpose protein folding models, IgFold is fine-tuned on antibody-specific structural data, enabling it to accurately model the critical complementarity-determining regions (CDRs), including the highly variable and challenging CDR-H3 loop, without relying on homologous template structures.

The model employs an invariant point attention (IPA) mechanism and a pre-trained antibody language model to capture the unique evolutionary and biophysical constraints of immunoglobulin domains. By predicting backbone coordinates and side-chain orientations in seconds rather than hours, IgFold provides a scalable solution for high-throughput antibody engineering tasks, including developability assessment, epitope mapping, and affinity maturation campaigns.

RAPID ANTIBODY STRUCTURE PREDICTION

Key Features of IgFold

IgFold is a specialized deep learning model that predicts antibody variable domain (Fv) structures directly from sequence in under 30 seconds, without relying on template databases or time-consuming physics simulations.

01

Template-Free Prediction

Unlike traditional homology modeling tools that require known structural templates, IgFold performs de novo structure prediction from sequence alone. The model uses a pre-trained protein language model (AntiBERTy) to generate rich sequence embeddings that capture evolutionary and biophysical constraints, enabling accurate prediction even for antibodies with novel CDR loops or rare framework alleles. This eliminates template bias and enables exploration of truly novel antibody space.

< 30 sec
Prediction Time
No Templates
Required Input
03

CDR Loop Accuracy

IgFold demonstrates particular strength in modeling the complementarity-determining regions (CDRs), especially the challenging CDR-H3 loop which exhibits the highest sequence and structural diversity. Key performance metrics include:

  • CDR-H3 RMSD: Median below 1.5 Å on benchmark sets
  • CDR-H1/H2: Sub-angstrom accuracy for canonical loop conformations
  • Framework regions: Highly accurate, typically < 0.5 Å RMSD The model captures non-canonical CDR-H3 conformations that template-based methods systematically miss.
< 1.5 Å
Median CDR-H3 RMSD
< 0.5 Å
Framework RMSD
05

PyRosetta Refinement Integration

IgFold structures can be optionally refined using PyRosetta, the Python interface to the Rosetta macromolecular modeling suite. This post-prediction step applies:

  • All-atom energy minimization to resolve steric clashes
  • Side-chain rotamer optimization for accurate side-chain packing
  • Loop closure protocols for CDR regions with high conformational entropy The refinement pipeline bridges the gap between fast deep learning predictions and physics-based accuracy, producing structures suitable for downstream docking and design workflows.
06

Nanobody and Single-Domain Support

Beyond conventional IgG Fv domains, IgFold accurately predicts structures for nanobodies (VHH domains) and other single-domain antibodies. These camelid-derived fragments possess characteristically elongated CDR3 loops that often form convex paratopes capable of binding cryptic epitopes. IgFold's template-free approach is particularly advantageous here, as nanobody structural databases remain sparse compared to conventional antibodies, making template-based methods unreliable.

ANTIBODY STRUCTURE PREDICTION COMPARISON

IgFold vs. AlphaFold2 for Antibodies

Head-to-head comparison of specialized antibody structure prediction (IgFold) versus general-purpose protein folding (AlphaFold2) for antibody variable domain modeling tasks.

FeatureIgFoldAlphaFold2AlphaFold-Multimer

Primary training domain

Antibody variable domains (Fv)

General protein structures

Protein complexes

Template-free prediction

Antibody-specific architecture

CDR-H3 loop accuracy

Superior (specialized)

Moderate

Moderate

Single-sequence inference speed

< 1 sec

Minutes to hours

Minutes to hours

Requires MSA input

Native nanobody support

Framework region accuracy

High

High

High

IgFold EXPLAINED

Frequently Asked Questions

Get clear, technical answers to the most common questions about IgFold, the deep learning model that predicts antibody variable domain structures directly from sequence in seconds.

IgFold is a specialized deep learning model designed for rapid, template-free prediction of antibody variable domain (Fv) structures directly from amino acid sequence data. Unlike general protein structure predictors that rely on multiple sequence alignments (MSAs) and template searches, IgFold employs a pre-trained antibody-specific language model to generate rich sequence embeddings. These embeddings are then processed by a graph neural network (GNN) that iteratively refines the 3D coordinates of the backbone atoms. The model predicts structures in a single forward pass, bypassing the computationally expensive co-evolutionary analysis required by tools like AlphaFold2. This architecture allows IgFold to capture the unique structural determinants of antibodies, including the critical complementarity-determining region (CDR) loops, particularly the hypervariable CDR-H3 loop, which is a primary driver of antigen binding specificity. The model was trained on a curated dataset of experimentally determined antibody structures from the Protein Data Bank (PDB), learning the intrinsic relationship between an antibody's sequence and its folded conformation without requiring homologous templates.

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.